Analyst Ratings for Pyxis Oncology Inc. (PYXS)
PYXS Rating Summary
PYXS Price Target Summary
- Highest: $8.00 (Jefferies)
- Lowest: $5.00 (RBC Capital)
- Average: $7.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.00 (+244.8%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$7.00 (+244.8%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/5/2026 | Wedbush | Robert Driscoll | New Coverage | Outperform (N/A) |
6.00 (N/A) |
1.76 (2.03) |
15.34% | Details |
| 9/4/2025 | Guggenheim » Updated 3/24/2026 |
Bradley Canino | New Coverage | Buy (N/A) |
7.00 (N/A) |
1.33 (2.03) |
52.63% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
